Compare Harley-Davidson Inc (HOG) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harley-Davidson Inc vs Revvity Inc — how do they compare? Harley-Davidson Inc trades at $26.91 (market cap $2.78B), while Revvity Inc trades at $115.76 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 4.6× Harley-Davidson Inc's market cap, and Harley-Davidson Inc pays the higher dividend (2.75%). Which is the better fit depends on your goals.
| HOG | RVTY | |
|---|---|---|
Market Cap | $2.78B | $12.91B |
Sector | Consumer Cyclical | Technology |
52-Week High | $31.03 | $117.75 |
52-Week Low | $17.19 | $82.26 |
Enterprise Value | $3.19B | $15.23B |
Dividend Yield | 2.75% | 0.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
